BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346
900 results:

  • 1. TRPS1 is a Highly Sensitive Marker for breast cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor Entities.
    Lennartz M; Löhr N; Höflmayer D; Dwertmann Rico S; von Bargen C; Kind S; Reiswich V; Viehweger F; Lutz F; Bertram V; Fraune C; Gorbokon N; Weidemann S; Blessin NC; Hube-Magg C; Menz A; Schlichter R; Krech T; Hinsch A; Burandt E; Sauter G; Simon R; Kluth M; Marx AH; Lebok P; Dum D; Minner S; Jacobsen F; Clauditz TS; Bernreuther C; Steurer S
    Am J Surg Pathol; 2024 Jun; 48(6):637-651. PubMed ID: 38647255
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic breast cancer Treated With Abemaciclib: Data From the SCRUM-Japan cancer Genome Screening Project.
    Hattori M; Serelli-Lee V; Naito Y; Yamanaka T; Yasojima H; Nakamura R; Fujisawa T; Imai M; Nakamura Y; Bando H; Kawaguchi T; Yoshino T; Iwata H
    JCO Precis Oncol; 2024 Apr; 8():e2300647. PubMed ID: 38635933
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Subtyping of triple-negative breast cancers: its prognostication and implications in diagnosis of breast origin.
    Hu H; Tong K; Tsang JY; Ko CW; Tam F; Loong TC; Tse GM
    ESMO Open; 2024 Apr; 9(4):102993. PubMed ID: 38613910
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Deep learning for high-resolution dose prediction in high dose rate brachytherapy for breast cancer treatment.
    Quetin S; Bahoric B; Maleki F; Enger SA
    Phys Med Biol; 2024 Apr; 69(10):. PubMed ID: 38604185
    [No Abstract]    [Full Text] [Related]  

  • 5. Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and gata3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours.
    Wu Y; Chen F; Pan L; Chao X; Li M; Luo R; Chen K; Zheng C; Du T; He J; Sun P
    Pathology; 2024 Jun; 56(4):516-527. PubMed ID: 38570266
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An integrated approach to understand the regulatory role of miR-27 family in breast cancer metastasis.
    Chakraborty S; Paul U; Banerjee S; Saha D; Banerjee S
    Biosystems; 2024 Apr; 238():105200. PubMed ID: 38565418
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer.
    Kaplan HG; Dowdell AK; Berry AB; Shimol RB; Robinson FL; Carney CA; Piening BD
    Breast Cancer Res Treat; 2024 Jun; 205(3):451-464. PubMed ID: 38523186
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hypofractionated whole breast IMRT with hdr brachytherapy boost in early-stage breast cancer: Long-term results from a single-center.
    Díaz-Gavela AA; Cerro Peñalver ED; Sanchez-Garcia S; Pardo-Perez E; Thuissard-Vasallo IJ; Andreu-Vázquez C; Molina López MY; Pena Huertas M; Guerrero-Gómez LL; Sanz-Rosa D; Lorenzo FC
    Brachytherapy; 2024; 23(3):342-354. PubMed ID: 38522961
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Gastric metastasis from breast cancer: five cases and a single-institutional review.
    Cheng M; Jia Z; Zhang G; Wang Y; Li S; Yang S; Li C; Geng C
    J Int Med Res; 2024 Mar; 52(3):3000605241233988. PubMed ID: 38483129
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Primary cutaneous apocrine carcinoma with RARA::NPEPPS fusion.
    Lenskaya V; Yang RK; Cho WC
    J Cutan Pathol; 2024 Jun; 51(6):419-423. PubMed ID: 38468567
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
    Nader-Marta G; Monteforte M; Agostinetto E; Cinquini M; Martins-Branco D; Langouo M; Llombart-Cusac A; Cortés J; Ignatiadis M; Torri V; Apolone G; Cappelletti V; Pruneri G; de Azambuja E; Di Cosimo S
    ESMO Open; 2024 Mar; 9(3):102390. PubMed ID: 38460249
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domain.
    Hu C; Huang H; Na J; Lumby C; Abozaid M; Holdren MA; Rao TJ; Karam R; Pesaran T; Weyandt JD; Csuy CM; Seelaus CA; Young CC; Fulk K; Heidari Z; Morais Lyra PC; Couch RE; Persons B; Polley EC; Gnanaolivu RD; Boddicker NJ; Monteiro ANA; Yadav S; Domchek SM; Richardson ME; Couch FJ
    Am J Hum Genet; 2024 Mar; 111(3):584-593. PubMed ID: 38417439
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical sequencing defines the somatic and germline mutation landscapes of Chinese HER2-Low breast cancer.
    Han BY; Chen C; Luo H; Lin CJ; Han XC; Nasir J; Shi JX; Huang W; Shao ZM; Ling H; Hu X
    Cancer Lett; 2024 Apr; 588():216763. PubMed ID: 38403109
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Whole-Genome Sequencing Analysis of Male breast cancer Unveils Novel Structural Events and Potential Therapeutic Targets.
    Al Assaad M; Michaud O; Semaan A; Sigouros M; Tranquille M; Phan A; Levine MF; Gundem G; Medina-Martínez JS; Papaemmanuil E; Manohar J; Wilkes D; Sboner A; Hoda SAF; Elemento O; Mosquera JM
    Mod Pathol; 2024 Apr; 37(4):100452. PubMed ID: 38369186
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Invasive micropapillary carcinoma of the breast and bilateral ovarian mature cystic teratoma with benign Brenner tumor in a postmenopausal woman - An uncommon occurrence.
    Ayyanar P; Mitra S; Imaduddin M; Muduly DK
    Indian J Pathol Microbiol; 2024; 67(1):189-191. PubMed ID: 38358219
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A Metabolic-Epigenetic Mechanism Directs Cell Fate and Therapeutic Sensitivity in breast cancer.
    Bernard MJ; Goldstein AS
    Cancer Res; 2024 May; 84(9):1382-1383. PubMed ID: 38330100
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The androgen receptor interacts with gata3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer.
    Hosseinzadeh L; Kikhtyak Z; Laven-Law G; Pederson SM; Puiu CG; D'Santos CS; Lim E; Carroll JS; Tilley WD; Dwyer AR; Hickey TE
    Genome Biol; 2024 Feb; 25(1):44. PubMed ID: 38317241
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genomic transcription factor binding site selection is edited by the chromatin remodeling factor CHD4.
    Saotome M; Poduval DB; Grimm SA; Nagornyuk A; Gunarathna S; Shimbo T; Wade PA; Takaku M
    Nucleic Acids Res; 2024 Apr; 52(7):3607-3622. PubMed ID: 38281186
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A Comparative Evaluation of TRPS1 and gata3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary gland.
    Salem A; Wu Y; Albarracin CT; Middleton LP; Kalhor N; Peng Y; Huang X; Aung PP; Chen H; Sahin AA; Ding Q
    Hum Pathol; 2024 Mar; 145():42-47. PubMed ID: 38262580
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Intraoperative Radiation Therapy Delivered by Brachytherapy in breast cancer: An Interim Analysis of a Phase 2 Trial.
    Wickberg Å; Prag C; Valachis A; Karlsson L; Johansson B
    Clin Breast Cancer; 2024 Apr; 24(3):243-252. PubMed ID: 38185607
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 45.